Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Drug News & Perspectives|January 5, 2006
Study focuses in on potential cause of antipsychotic-induced diabetesMichael F O'NeillCurrent Opinion in Pharmacology|March 8, 2011
It might be a big family but the pain remains-last chance saloon for selective 5-HT receptor ligands?Nick Andrews, Michael F O'NeillJournal of Psychopharmacology (Oxford, England)|December 12, 2013
Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychoticsJordi S Silvestre, Michael F O'Neill, Josep R ProusBehavioural Brain Research|March 23, 2004
The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after strokeGary Gilmour, Susan D Iversen, Michael F O'Neill, et al.Neuropharmacology|August 28, 2003
Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in miceMichael F O'Neill, Claire Heron-Maxwell, Michael W Conway, et al.Psychopharmacology|April 12, 2005
Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult ratsMichael F O'neill, Graham Sanger, Paul L Ornstein, et al.Behavioural Brain Research|August 18, 2005
Amphetamine promotes task-dependent recovery following focal cortical ischaemic lesions in the ratGary Gilmour, Susan D Iversen, Michael F O'Neill, et al.Pharmacology, Biochemistry, and Behavior|January 29, 2002
Behavioural pharmacology of polygalasaponins indicates potential antipsychotic efficacyIn-Won Chung, Nicholas A Moore, Won-Keun Oh, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depressionLorraine Axford, John R Boot, Terrence M Hotten, et al.Pageof 1